Novel splice-site mutations as the cause of FAP-related cancer in two families K Sweet, B McIlhatton, V McConnell, W Logan and C Graham Regional Molecular.

Slides:



Advertisements
Similar presentations
Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.
Advertisements

Familial adenomatous polyposis
Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
1. Define, with examples, the following: a) Exon Splicing Enhancer b) Nonsense Mediated Decay c) Cryptic Splice Site How would you investigate the effect.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
The Contribution of the BRCA1 and BRCA2 Genes to Hereditary Breast Cancer and Ovarian Cancer in Israel Tieling Wang Department of Human Genetics Hadassah.
MSH2 and Human Nonpolyposis Colon Cancer Yael Aschner.
SMAD4/DPC4: A Tumor Suppressor James Brooks March 23 rd, 2006.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
1 Alternative Splicing. 2 Eukaryotic genes Splicing Mature mRNA.
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
BRCA Genes Dallas Henson.
Genetics & Colorectal Cancer
Tumor Supressor Gene Non-functional TSG Mutations increasing risk of cancer “Loss of function” mutation Proto-oncogene Oncogene (Hyperactive or unregulated.
Fine Structure and Analysis of Eukaryotic Genes
Detection of complex mutations in Swedish FAP familes Anna Rohlin, 1 Yvonne Engwall, 1 Josephine Wernersson 1, Jan Björk, 2 and.
Familial Cancer. General Principles Mutations inherited through germ cells contribute to a minority of tumours Two hits usually needed germline/somatic.
Expanded PLA2G6 Copy Number Variant Analysis in Patients with Infantile Neuroaxonal Dystrophy (INAD) Danielle Crompton, P. K. Rehal, L. MacPherson, K.
Approach to a Mass of Unknown Significance Location Kinetics Systemic Manifestations.
Amber Ellis and Russell Brown
Genome Organization and Evolution. Assignment For 2/24/04 Read: Lesk, Chapter 2 Exercises 2.1, 2.5, 2.7, p 110 Problem 2.2, p 112 Weblems 2.4, 2.7, pp.
Variable gene expression and reduced penetrance in familial adenomatous polyposis Rohlin A* 1, Wernersson J 1, Björk J 2, and Nordling M 1 Dept of Clinical.
Genetic Variation in Individuals and Populations: Mutation and Polymorphism Chapter 9 Thompson and Thompson (only mutation) Dr. M. Fardaei 1.
Aims and objectives of the workshop David Moore. Aims Classification of variants is subjective and NEQAS results suggest this is not a major problem To.
A Diagnostic Testing Service for Hypophosphatemic Rickets
A brief comment on nomenclature. A croe (coding region of an exon) is not exactly an exon Steve Mount ISMB SIG meeting on alternative splicing June 23,
Variable gene expression in APC- and MUTYH mutation negative FAP and AFAP patients Rohlin A* 1, Wernersson J 1, Björk J 2, and Nordling M 1 Dept of Clinical.
Chapter 3 The Interrupted Gene.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
Finding genes in the genome
MLH1: Hereditary non- polyposis colon cancer (HNPCC) By: Alison Edge.
Variant Classification and Reclassification. Introduction This slide presentation covers several topics pertaining to Variant classification, reclassification.
Do you have 3 or more affected relatives? (2 or less)
Novel IL7R Mutation in a T-B+NK+ SCID Infant Y Chang 1, P Sriaroon 2, GA Jervis 1, J Shi 1, MJ Sutcliffe 1, A Petrovic 1, JW Leiding 2 1 All Children’s.
Hereditary Cancer Predisposition: Updates in Genetic Testing
Institute of Biomedical & Genetic Engineering (IBGE)
Cancer Can Not Comfort But Your Family Can
FAMILIAL ADENOMATOUS POLYPOSIS
Sequence Alignments—part 2
SGN23 The Organization of the Human Genome
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Sequence analyses and evolutionary conservation of the CLDN10 gene and the identified CLDN10 variants. Sequence analyses and evolutionary conservation.
by Wen-feng Xu, Zhi-wei Xie, Dominic W. Chung, and Earl W. Davie
Genetic testing for high-risk colon cancer patients1
Relationship between Genotype and Phenotype
A Novel Gene Causing a Mendelian Audiogenic Mouse Epilepsy
Analysis of Rare APC Variants at the mRNA Level
Activation of a Cryptic Splice Site of PTEN and Loss of Heterozygosity in Benign Skin Lesions in Cowden Disease  Stephen J. Meltzer, Manfred Wolter  Journal.
Unit 7 Part 2 Notes: From Gene to Protein
A Presenilin-1 Truncating Mutation Is Present in Two Cases with Autopsy-Confirmed Early-Onset Alzheimer Disease  Carolyn Tysoe, Joanne Whittaker, John.
Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays  Lucia Pérez-Cabornero,
Sarah E. Kerr, Cheryl B. Thomas, Stephen N. Thibodeau, Matthew J
The Gene Mutated in Variant Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN6) and in nclf Mutant Mice Encodes a Novel Predicted Transmembrane Protein 
Volume 57, Issue 3, Pages (March 2000)
Gene Structure.
Genotype–Phenotype Correlation in Recessive Dystrophic Epidermolysis Bullosa: When Missense Doesn't Make Sense  Vesarat Wessagowit, Soo-Chan Kim, Se Woong.
Figure 1 Pedigree and genetic findings
Mutation in pycr1a exon 3 disrupts predicted exonic splicing enhancers
(A) yellow cDNA comparison among wild-type and ch mutants
Figure 1 Schematic of the OPA3 gene and OPA3 protein isoform b
KIT mutations in GISTs. A, amino acid sequence of KIT exon 11 mutations in clinical GIST biopsies. –, amino acids that are deleted; italicized amino acids,
Figure Genetic characterization of the novel GYG1 gene mutation (A) GYG1_cDNA sequence and position of primers used. Genetic characterization of the novel.
Gene Structure.
Presentation transcript:

Novel splice-site mutations as the cause of FAP-related cancer in two families K Sweet, B McIlhatton, V McConnell, W Logan and C Graham Regional Molecular Genetics Laboratory, Belfast

APC-Associated polyposis conditions Familial adenomatous polyposis (FAP) Familial adenomatous polyposis (FAP) >100 adenomatous colonic polyps >100 adenomatous colonic polyps Often thousands of colonic polyps Often thousands of colonic polyps Polyps present throughout the colon Polyps present throughout the colon Early age of onset Early age of onset Germline mutations in APC gene Germline mutations in APC gene Autosomal dominant Autosomal dominant Attenuated FAP (AFAP) Attenuated FAP (AFAP) Fewer colonic polyps (<100) Fewer colonic polyps (<100) Later age of onset Later age of onset

APC Gene /9a (aa) Ex Classic FAP MUTATION CLUSTER REGION bp mutation Hot Spots AFAP 436 AFAP 1596 Grady and Markowitz B-CATENIN BINDING DOMAIN B-CATENIN DEGRADATION DOMAIN MICROTUBULE BINDING DOMAIN FUNCTONAL DOMAINS ARMADILLO REPEATS EB1 BINDING DOMAIN

APC Mutations Mutation Type No. Mutations (%) Small deletions 356 (41%) Missense/nonsense 235 (27%) Small insertions 131 (15%) Gross deletions 54 (6%) Splicing 49 (5%) Small indels 17 (2%) Regulatory 3 (<1%) Molecular genetic testing using range of techniques including MLPA, PTT and DNA sequencing Mutation detection rate – up to 90%

Case 1 9 sibs II:1II:2II:3II:4II:5II:6II:7 ? III:1 Colonoscopy - > polyps located proximal and distal to tumour Suspected family history of colon cancer on maternal side Age 47- Adenocarcinoma APC Ex 1-14 screen APC Ex 15 PTT - Negative c A>G in intron 10

APC Gene AFAPFAP with CHRPEAFAP Fruitfly and SpliceSiteFinder prediction programmes predicted use of alternative splice site. Score – 80.6 Previously reported in large European study – Pathogenicity undetermined Friedl & Aretz, /9a (aa) Ex ARMADILLO REPEATS c A>G CCCTTTTTAA TTAG GGGGACTAC G A -Splice acceptor site Exon 11

Molecular analysis cDNA CCCTTTTTAA A TTAG GGGGACTAC G Ex 11 Intron 10 c A>G DNA Splice acceptor site AATGAACTAGTTAGGGGGACTACAGGC,,,,TGA Ex10 Ex11 4bp insertion – (p.G470Vfsx15) RNA Term CCCTTTTTAAGTTAG GGGGACTAC Alternative splice site NNM 250bp 254bp

MYH gene - Negative APC Ex 1-14 Screen APC Ex 15 PTT - Negative c.423 G>T (p.R141S) Exon 4 APC gene Case 2 Age 55 - Carcinoma of sigmoid colon Age 62 - Multiple polyps throughout colon II:1II:2II:3II:4II:5II:6 Breast Ca Melanoma Jejunal Ca ? Colon Ca III.2

AFAP III:2III:3III:4 III:5 AFAP II:1II:2II:3II:4II:5II:6 Case 2 c.423 G>T Splicing mutation PRESENT Breast Ca

AFAP APC Gene Conserved amino acid sequence Predicted to disrupt splice-site – (Fruitfly and SpliceSiteFinder and prediction programmes) Reported by Aretz et al., Human Mutation 24(5): /9a (aa) 4 c.423G>T p.R141S

109bp Ex3Ex4Ex5 DNA AAGAGAG GTCAATTGCTTCTTGCT T Intron 3Exon 4 c.423G>T Ex3Ex5 Ex3Ex4 RNA II.2 N II.4III.3 Molecular analysis Exon skipping confirmed by sequence analysis of the cDNA product across junction.

Summary Case 1 – Atypical FAP Case 1 – Atypical FAP c A>G mutation – c A>G mutation – Splice-site prediction programmes Splice-site prediction programmes RNA studies RNA studies Selection of an alternative splice site. Selection of an alternative splice site. Case 2 – AFAP Case 2 – AFAP c.423 G>T (p.R141S) missense mutation – c.423 G>T (p.R141S) missense mutation – Amino acid conservation Amino acid conservation Segregation with disease Segregation with disease Splice site prediction programmes Splice site prediction programmes RNA studies RNA studies Exon skipping possibly due to possible effect on exonic splicing enhancer motifs (ESEs). (Aretz et al., 2004). Exon skipping possibly due to possible effect on exonic splicing enhancer motifs (ESEs). (Aretz et al., 2004).

To conclude… Splicing mutations can cause FAP and warrant further investigation Splicing mutations can cause FAP and warrant further investigation CMGS Best Practice Guidelines on the interpretation and reporting of unclassified variants CMGS Best Practice Guidelines on the interpretation and reporting of unclassified variants